Literature DB >> 18187400

Feasibility of whole-body MR with T2- and T1-weighted real-time steady-state free precession sequences during continuous table movement to depict metastases.

Katja Brauck1, Michael O Zenge, Florian M Vogt, Harald H Quick, Frank Stock, Tanja Trarbach, Mark E Ladd, Jörg Barkhausen.   

Abstract

The purpose of the study was to prospectively evaluate a whole-body magnetic resonance (MR) imaging protocol to help depict metastases by using unenhanced T2-weighted and contrast material-enhanced T1-weighted real-time sequences during continuous table movement. The study was conducted after approval of the local institutional review board and written informed consent were obtained. In 11 patients with positron emission tomographic (PET) scans positive for tumors and known metastases, whole-body MR imaging, including T2- and T1-weighted sequences, was performed before and after contrast material administration. A high-precision laser position sensor was used to register the table position for off-line multiplanar reformations of the acquired transverse whole-body data sets. Seventy-three of 75 metastases detected by using PET/computed tomography were correctly diagnosed by using MR imaging. Metastases with a diameter exceeding 5 mm could be visualized in all anatomic regions. (c) RSNA, 2008.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18187400     DOI: 10.1148/radiol.2463062017

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Prospective head-to-head comparison of 11C-choline-PET/MR and 11C-choline-PET/CT for restaging of biochemical recurrent prostate cancer.

Authors:  Matthias Eiber; Isabel Rauscher; Michael Souvatzoglou; Tobias Maurer; Markus Schwaiger; Konstantin Holzapfel; Ambros J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-12       Impact factor: 9.236

2.  Comparison of a new whole-body continuous-table-movement protocol versus a standard whole-body MR protocol for the assessment of multiple myeloma.

Authors:  S Weckbach; H J Michaely; A Stemmer; S O Schoenberg; D J Dinter
Journal:  Eur Radiol       Date:  2010-06-24       Impact factor: 5.315

Review 3.  Whole-body diffusion-weighted and proton imaging: a review of this emerging technology for monitoring metastatic cancer.

Authors:  Michael A Jacobs; Li Pan; Katarzyna J Macura
Journal:  Semin Roentgenol       Date:  2009-04       Impact factor: 0.800

4.  Whole-body MRI using a sliding table and repositioning surface coil approach.

Authors:  Taro Takahara; Thomas Kwee; Satoshi Kibune; Reiji Ochiai; Tetsuro Sakamoto; Tetsu Niwa; Marc Van Cauteren; Peter Luijten
Journal:  Eur Radiol       Date:  2009-12-08       Impact factor: 5.315

5.  Exploring temporospatial changes in glucose metabolic disorder, learning, and memory dysfunction in a rat model of diffuse axonal injury.

Authors:  Jia Li; Lei Gu; Dong-Fu Feng; Fang Ding; Guangyao Zhu; Jiandong Rong
Journal:  J Neurotrauma       Date:  2012-11-20       Impact factor: 5.269

6.  A randomized, double-blind, crossover comparison of novel continuous bed motion versus traditional bed position whole-body PET/CT imaging.

Authors:  Imke Schatka; Desiree Weiberg; Stephanie Reichelt; Nicole Owsianski-Hille; Thorsten Derlin; Georg Berding; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-06       Impact factor: 9.236

7.  What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis : imaging for recurrent colorectal cancer.

Authors:  Monique Maas; Iris J G Rutten; Patty J Nelemans; Doenja M J Lambregts; Vincent C Cappendijk; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-06       Impact factor: 9.236

8.  Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.

Authors:  Thomas C Kwee; Robert M Kwee
Journal:  Eur Radiol       Date:  2008-10-17       Impact factor: 5.315

9.  Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.

Authors:  Shivani Ahlawat; Laura M Fayad; Muhammad Shayan Khan; Miriam A Bredella; Gordon J Harris; D Gareth Evans; Said Farschtschi; Michael A Jacobs; Avneesh Chhabra; Johannes M Salamon; Ralph Wenzel; Victor F Mautner; Eva Dombi; Wenli Cai; Scott R Plotkin; Jaishri O Blakeley
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910

Review 10.  Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review.

Authors:  Mario Ciliberto; Fabio Maggi; Giorgio Treglia; Federico Padovano; Lucio Calandriello; Alessandro Giordano; Lorenzo Bonomo
Journal:  Radiol Oncol       Date:  2013-07-30       Impact factor: 2.991

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.